for mine biotechs are too hit and miss, massive odds against successful commercialisation of a drug nowadays ---> US$1 bn plus so very few get that far, agree that many large drug companies are partnering junior biotechs once some of the risk is out of it but only a lucky small minority hit that jackpot
